Mouna Tahmi1, Wassim Bou-Zeid2, Qolamreza R Razlighi2,3. 1. Department of Neurology, Columbia University Medical Center, New York, New York; and mt3288@cumc.columbia.edu. 2. Department of Neurology, Columbia University Medical Center, New York, New York; and. 3. Department of Biomedical Engineering, Columbia University, New York, New York.
Abstract
Spatial heterogeneity in the accumulation of amyloid-β plaques throughout the brain during asymptomatic as well as clinical stages of Alzheimer disease calls for precise localization and quantification of this protein using PET imaging. To address this need, we have developed and evaluated a technique that quantifies the extent of amyloid-β pathology on a millimeter-by-millimeter scale in the brain with unprecedented precision using data from PET scans. Methods: An intermodal and intrasubject registration with normalized mutual information as the cost function was used to transform all FreeSurfer neuroanatomic labels into PET image space, which were subsequently used to compute regional SUV ratio (SUVR). We have evaluated our technique using postmortem histopathologic staining data from 52 older participants as the standard-of-truth measurement. Results: Our method resulted in consistently and significantly higher SUVRs in comparison to the conventional method in almost all regions of interest. A 2-way ANOVA revealed a significant main effect of method as well as a significant interaction effect of method on the relationship between computed SUVR and histopathologic staining score. Conclusion: These findings suggest that processing the amyloid-β PET data in subjects' native space can improve the accuracy of the computed SUVRs, as they are more closely associated with the histopathologic staining data than are the results of the conventional approach.
Spatial heterogeneity in the accumulation of amyloid-β plaques throughout the brain during asymptomatic as well as clinical stages of Alzheimer disease calls for precise localization and quantification of this protein using PET imaging. To address this need, we have developed and evaluated a technique that quantifies the extent of amyloid-β pathology on a millimeter-by-millimeter scale in the brain with unprecedented precision using data from PET scans. Methods: An intermodal and intrasubject registration with normalized mutual information as the cost function was used to transform all FreeSurfer neuroanatomic labels into PET image space, which were subsequently used to compute regional SUV ratio (SUVR). We have evaluated our technique using postmortem histopathologic staining data from 52 older participants as the standard-of-truth measurement. Results: Our method resulted in consistently and significantly higher SUVRs in comparison to the conventional method in almost all regions of interest. A 2-way ANOVA revealed a significant main effect of method as well as a significant interaction effect of method on the relationship between computed SUVR and histopathologic staining score. Conclusion: These findings suggest that processing the amyloid-β PET data in subjects' native space can improve the accuracy of the computed SUVRs, as they are more closely associated with the histopathologic staining data than are the results of the conventional approach.
Authors: S S Mirra; A Heyman; D McKeel; S M Sumi; B J Crain; L M Brownlee; F S Vogel; J P Hughes; G van Belle; L Berg Journal: Neurology Date: 1991-04 Impact factor: 9.910
Authors: Mark E Schmidt; Ping Chiao; Gregory Klein; Dawn Matthews; Lennart Thurfjell; Patricia E Cole; Richard Margolin; Susan Landau; Norman L Foster; N Scott Mason; Susan De Santi; Joyce Suhy; Robert A Koeppe; William Jagust Journal: Alzheimers Dement Date: 2014-11-24 Impact factor: 21.566
Authors: Susan M Landau; Christopher Breault; Abhinay D Joshi; Michael Pontecorvo; Chester A Mathis; William J Jagust; Mark A Mintun Journal: J Nucl Med Date: 2012-11-19 Impact factor: 10.057
Authors: Osama Sabri; Marwan N Sabbagh; John Seibyl; Henryk Barthel; Hiroyasu Akatsu; Yasuomi Ouchi; Kohei Senda; Shigeo Murayama; Kenji Ishii; Masaki Takao; Thomas G Beach; Christopher C Rowe; James B Leverenz; Bernardino Ghetti; James W Ironside; Ana M Catafau; Andrew W Stephens; Andre Mueller; Norman Koglin; Anja Hoffmann; Katrin Roth; Cornelia Reininger; Walter J Schulz-Schaeffer Journal: Alzheimers Dement Date: 2015-03-28 Impact factor: 21.566
Authors: Adam S Fleisher; Kewei Chen; Xiaofen Liu; Auttawut Roontiva; Pradeep Thiyyagura; Napatkamon Ayutyanont; Abhinay D Joshi; Christopher M Clark; Mark A Mintun; Michael J Pontecorvo; P Murali Doraiswamy; Keith A Johnson; Daniel M Skovronsky; Eric M Reiman Journal: Arch Neurol Date: 2011-07-11
Authors: Benjamin M Doherty; Stephanie A Schultz; Jennifer M Oh; Rebecca L Koscik; N Maritza Dowling; Todd E Barnhart; Dhanabalan Murali; Catherine L Gallagher; Cynthia M Carlsson; Barbara B Bendlin; Asenath LaRue; Bruce P Hermann; Howard A Rowley; Sanjay Asthana; Mark A Sager; Brad T Christian; Sterling C Johnson; Ozioma C Okonkwo Journal: Alzheimers Dement (Amst) Date: 2015-06-01
Authors: Alexandria L Irace; Brady Q Rippon; Adam M Brickman; José A Luchsinger; Justin S Golub Journal: Otol Neurotol Date: 2022-03-01 Impact factor: 2.311
Authors: Priya Palta; Brady Rippon; Mouna Tahmi; Michelle Pardo; Aubrey Johnson; Zeljko Tomljanovic; Hengda He; Krystal K Laing; Qolamreza R Razlighi; Jeanne A Teresi; Herman Moreno; Adam M Brickman; William C Kreisl; José A Luchsinger Journal: Neurobiol Aging Date: 2021-03-23 Impact factor: 5.133